1. Home
  2. MED vs ELDN Comparison

MED vs ELDN Comparison

Compare MED & ELDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MEDIFAST INC

MED

MEDIFAST INC

HOLD

Current Price

$10.88

Market Cap

120.6M

ML Signal

HOLD

Logo Eledon Pharmaceuticals Inc.

ELDN

Eledon Pharmaceuticals Inc.

HOLD

Current Price

$1.58

Market Cap

120.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MED
ELDN
Founded
1980
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Packaged Foods
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
120.6M
120.8M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
MED
ELDN
Price
$10.88
$1.58
Analyst Decision
Hold
Strong Buy
Analyst Count
1
2
Target Price
$16.50
$8.50
AVG Volume (30 Days)
200.3K
3.8M
Earning Date
11-03-2025
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.02
N/A
Revenue
$429,695,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$450.87
N/A
Revenue Growth
N/A
N/A
52 Week Low
$10.36
$1.35
52 Week High
$21.98
$5.08

Technical Indicators

Market Signals
Indicator
MED
ELDN
Relative Strength Index (RSI) 37.36 35.40
Support Level $10.72 $1.47
Resistance Level $11.12 $1.68
Average True Range (ATR) 0.33 0.16
MACD 0.07 0.03
Stochastic Oscillator 48.37 48.97

Price Performance

Historical Comparison
MED
ELDN

About MED MEDIFAST INC

Medifast Inc is a old health and wellness company known for its habit-based and coach-guided lifestyle solution OPTAVIA, which provides people with a simple, yet comprehensive approach to address obesity and support a healthy life. OPTAVIA provides unparalleled coaching support along with community, tailored nutrition and healthy habits, and empowers people to master their weight loss journey through each stage of life. The company has access to GLP-1 medications where clinically appropriate. Medifast remains committed to its mission of offering Lifelong Transformation, Making a Healthy Lifestyle Second Nature.

About ELDN Eledon Pharmaceuticals Inc.

Eledon Pharmaceuticals Inc is a clinical-stage biotechnology company. The firm is focused on transplantation and autoimmune diseases. It targets the CD40L pathway to develop potential treatments for patients living with an autoimmune disease, patients requiring an organ or cell-based transplant, and patients living with ALS. The company's compound in development is tegoprubart, an IgG1, an anti-CD40L antibody with high affinity for the CD40 Ligand, a well-validated biological target that has broad therapeutic potential.

Share on Social Networks: